Physician

Nitin Gupta, M.D., M.P.H.

According to 2025 Medicare claims, Nitin Gupta, M.D., M.P.H. (NPI: 1962454835) practices ophthalmology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is RETINA ASSOCIATES, PLLC (NPI: 1760408397; TIN: 562043271) and primary practice location at 27609-7327.

Gupta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 971 traditional Medicare patients, billed 28,914 HCPCS/CPT codes, and received $4,904,278 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 91 prescription claims across 31 beneficiaries totaling $4,399 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 38 records totaling $1,209. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,887,019 to $4,904,278. In contrast, Part D prescription costs have fallen sharply in recent years, from $19,931 to $4,399. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.0M$5.9M2015 Medicare payment: $2,887,019 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,249,262 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,513,271 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,779,386 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,637,694 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,928,428 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,937,554 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,741,552 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,759,597 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,904,278 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,47119,663$2,887,019
20161,55521,713$3,249,262
20171,35118,475$3,513,271
20181,22317,115$3,779,386
20191,50819,259$4,637,694
20201,35020,136$5,928,428
20211,11518,308$5,937,554
202290915,495$4,741,552
202391321,770$4,759,597
202497128,914$4,904,278

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$20K$39K2015 Drug cost: $19,931 (USD; Tot_Drug_Cst)2016 Drug cost: $25,551 (USD; Tot_Drug_Cst)2017 Drug cost: $39,403 (USD; Tot_Drug_Cst)2018 Drug cost: $32,298 (USD; Tot_Drug_Cst)2019 Drug cost: $29,124 (USD; Tot_Drug_Cst)2020 Drug cost: $25,316 (USD; Tot_Drug_Cst)2021 Drug cost: $13,842 (USD; Tot_Drug_Cst)2022 Drug cost: $19,449 (USD; Tot_Drug_Cst)2023 Drug cost: $9,526 (USD; Tot_Drug_Cst)2024 Drug cost: $4,399 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201592270$19,931
2016105322$25,551
201799317$39,403
201896322$32,298
201996255$29,124
202082228$25,316
202170176$13,842
202265186$19,449
202357127$9,526
20243191$4,399

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg4964,876$654
67028Injection of drug into eye6652,638$97
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more369469$69
92012Established patient problem focused exam of visual system448566$64
92134Imaging of retina9593,021$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate13471$565
Ketorolac TromethamineKetorolac Tromethamine12378$328
LatanoprostLatanoprost16668$106
Brimonidine TartrateBrimonidine Tartrate11489$75

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$1,209Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nitin Gupta, M.D., M.P.H.?

Tedicare shows public-source Medicare data for Nitin Gupta, M.D., M.P.H. (NPI 1962454835), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nitin Gupta, M.D., M.P.H. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nitin Gupta, M.D., M.P.H.?

Nitin Gupta, M.D., M.P.H. is linked to RETINA ASSOCIATES, PLLC (billing NPI 1760408397) in the available physician profile data.

Does Nitin Gupta, M.D., M.P.H. have Open Payments data?

Nitin Gupta, M.D., M.P.H. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.